Murray A W, Brockway M S, Kenny G N
University Department of Anaesthesia, Royal Infirmary, Glasgow.
Br J Anaesth. 1989 Nov;63(5):601-3. doi: 10.1093/bja/63.5.601.
The cardiorespiratory effects of a new nonopioid analgesic, ketorolac tromethamine, were compared with alfentanil as part of a balanced technique in which anaesthesia was maintained by a constant infusion of propofol. Twenty patients were allocated randomly to receive a single dose of either ketorolac 30 mg or alfentanil 0.5 mg. The study medication was given during the anaesthetic when the rate of ventilation had been stable (+/- 1 b.p.m.) for 5 min. Measurements of ventilatory rate, end-tidal carbon dioxide partial pressure, arterial oxygen saturation (SaO2), heart rate and systemic arterial pressure were made at 1-min intervals for 15 min following the test drug. Patients having alfentanil developed significant decreases in ventilatory rate, heart rate and mean arterial pressure. A significant increase in end-tidal carbon dioxide partial pressure occurred also. No changes occurred in any of the measured variables in the ketorolac group.
作为一种平衡技术的一部分,将新型非阿片类镇痛药酮咯酸氨丁三醇的心肺效应与阿芬太尼进行了比较,在该平衡技术中,通过持续输注丙泊酚维持麻醉。20名患者被随机分配接受单次剂量的30毫克酮咯酸或0.5毫克阿芬太尼。研究药物在麻醉期间通气率稳定(±1次/分钟)5分钟后给予。在给予试验药物后15分钟内,每隔1分钟测量通气率、呼气末二氧化碳分压、动脉血氧饱和度(SaO2)、心率和体循环动脉压。使用阿芬太尼的患者通气率、心率和平均动脉压显著下降。呼气末二氧化碳分压也显著升高。酮咯酸组的任何测量变量均未发生变化。